vs
Strive, Inc.（ASST）与HCW Biologics Inc.（HCWB）财务数据对比。点击上方公司名可切换其他公司
HCW Biologics Inc.的季度营收约是Strive, Inc.的1.5倍（$394.8K vs $255.0K），HCW Biologics Inc.净利率更高（-854.4% vs -75406.7%，领先74552.2%），HCW Biologics Inc.同比增速更快（-70.2% vs -74.1%），过去两年Strive, Inc.的营收复合增速更高（77.6% vs -45.8%）
斯特赖夫资产管理是一家2022年成立的美国投资管理机构，总部位于俄亥俄州哥伦布市，是斯特赖夫企业股份有限公司旗下子公司。该机构提供共同基金、交易所交易产品以及财富管理服务，是美国证监会注册的投资顾问。
HCW Biologics Inc.是一家临床阶段生物技术企业，专注于研发针对肿瘤、慢性炎症及自身免疫疾病领域未满足医疗需求的新型免疫疗法及相关生物制品，目前主要在美国运营，推进多款管线候选药物的早中期临床试验。
ASST vs HCWB — 直观对比
营收规模更大
HCWB
是对方的1.5倍
$255.0K
营收增速更快
HCWB
高出3.9%
-74.1%
净利率更高
HCWB
高出74552.2%
-75406.7%
两年增速更快
ASST
近两年复合增速
-45.8%
损益表 — Q3 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $255.0K | $394.8K |
| 净利润 | $-192.3M | $-3.4M |
| 毛利率 | — | 20.0% |
| 营业利润率 | -17288.6% | -795.9% |
| 净利率 | -75406.7% | -854.4% |
| 营收同比 | -74.1% | -70.2% |
| 净利润同比 | -2726.9% | 68.4% |
| 每股收益（稀释后） | $-0.22 | $-10.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASSTHCWB
| Q3 25 | $255.0K | — | ||
| Q2 25 | $173.3K | — | ||
| Q1 25 | $170.7K | — | ||
| Q4 24 | $212.8K | $394.8K | ||
| Q3 24 | $984.0K | $426.4K | ||
| Q2 24 | $93.0K | $618.9K | ||
| Q1 24 | $124.8K | $1.1M | ||
| Q4 23 | $80.9K | $1.3M |
净利润ASSTHCWB
| Q3 25 | $-192.3M | — | ||
| Q2 25 | $-8.9M | — | ||
| Q1 25 | $-3.7M | — | ||
| Q4 24 | $-4.1M | $-3.4M | ||
| Q3 24 | $-6.8M | $-3.9M | ||
| Q2 24 | $-5.9M | $-15.3M | ||
| Q1 24 | $-4.8M | $-7.5M | ||
| Q4 23 | $-1.3M | $-10.7M |
毛利率ASSTHCWB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 20.0% | ||
| Q3 24 | — | 20.0% | ||
| Q2 24 | — | 29.2% | ||
| Q1 24 | — | 54.6% | ||
| Q4 23 | — | 19.1% |
营业利润率ASSTHCWB
| Q3 25 | -17288.6% | — | ||
| Q2 25 | -1553.9% | — | ||
| Q1 25 | -970.5% | — | ||
| Q4 24 | -5889.5% | -795.9% | ||
| Q3 24 | -712.4% | -864.1% | ||
| Q2 24 | -1857.2% | -2445.8% | ||
| Q1 24 | -1110.9% | -665.1% | ||
| Q4 23 | -1667.7% | -813.3% |
净利率ASSTHCWB
| Q3 25 | -75406.7% | — | ||
| Q2 25 | -5122.4% | — | ||
| Q1 25 | -2195.6% | — | ||
| Q4 24 | -1935.5% | -854.4% | ||
| Q3 24 | -691.3% | -915.1% | ||
| Q2 24 | -6313.1% | -2469.1% | ||
| Q1 24 | -3837.7% | -662.8% | ||
| Q4 23 | -1667.7% | -806.7% |
每股收益（稀释后）ASSTHCWB
| Q3 25 | $-0.22 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.13 | — | ||
| Q4 24 | $-5.62 | $-10.47 | ||
| Q3 24 | $-3.06 | $-4.13 | ||
| Q2 24 | $-0.58 | $-16.16 | ||
| Q1 24 | $-0.49 | $-0.20 | ||
| Q4 23 | $-0.88 | $-0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $109.1M | $4.7M |
| 总债务越低越好 | — | $7.4M |
| 股东权益账面价值 | $779.4M | $-6.8M |
| 总资产 | $792.6M | $30.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASSTHCWB
| Q3 25 | $109.1M | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $6.2M | $4.7M | ||
| Q3 24 | $2.1M | $998.2K | ||
| Q2 24 | $1.9M | $1.2M | ||
| Q1 24 | $1.9M | $4.1M | ||
| Q4 23 | $2.9M | $3.6M |
总债务ASSTHCWB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.4M | ||
| Q3 24 | — | $6.5M | ||
| Q2 24 | — | $9.9M | ||
| Q1 24 | — | $8.3M | ||
| Q4 23 | — | $6.3M |
股东权益ASSTHCWB
| Q3 25 | $779.4M | — | ||
| Q2 25 | $10.7M | — | ||
| Q1 25 | $19.6M | — | ||
| Q4 24 | $23.3M | $-6.8M | ||
| Q3 24 | $27.5M | $-10.0M | ||
| Q2 24 | $5.4M | $-6.3M | ||
| Q1 24 | $11.3M | $8.7M | ||
| Q4 23 | $16.1M | $13.5M |
总资产ASSTHCWB
| Q3 25 | $792.6M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $28.2M | $30.2M | ||
| Q3 24 | $2.6M | $26.6M | ||
| Q2 24 | $2.4M | $26.8M | ||
| Q1 24 | $2.1M | $30.4M | ||
| Q4 23 | $3.1M | $28.5M |
负债/权益比ASSTHCWB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.95× | ||
| Q4 23 | — | 0.47× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.0M | $-2.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.9M |
| 自由现金流率自由现金流/营收 | — | -746.8% |
| 资本支出强度资本支出/营收 | 0.0% | 28.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-14.5M |
8季度趋势，按日历期对齐
经营现金流ASSTHCWB
| Q3 25 | $-14.0M | — | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | $-21.6M | $-2.8M | ||
| Q3 24 | $-13.2M | $-2.9M | ||
| Q2 24 | $-1.3M | $-4.9M | ||
| Q1 24 | $-1.0M | $-3.6M | ||
| Q4 23 | $-854.1K | $-3.9M |
自由现金流ASSTHCWB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-21.6M | $-2.9M | ||
| Q3 24 | $-13.4M | $-3.0M | ||
| Q2 24 | $-1.3M | $-4.9M | ||
| Q1 24 | $-1.1M | $-3.7M | ||
| Q4 23 | — | $-7.6M |
自由现金流率ASSTHCWB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -10161.2% | -746.8% | ||
| Q3 24 | -1360.3% | -695.0% | ||
| Q2 24 | -1379.4% | -788.7% | ||
| Q1 24 | -844.7% | -331.4% | ||
| Q4 23 | — | -574.8% |
资本支出强度ASSTHCWB
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 11.3% | 28.7% | ||
| Q3 24 | 18.8% | 8.7% | ||
| Q2 24 | 3.1% | 3.0% | ||
| Q1 24 | 9.5% | 11.5% | ||
| Q4 23 | — | 280.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
